Critical roles for NO in regulating cell and tissue physiology are broadly appreciated, but aspects remain to be explored. In the mollusc Pleurobranchaea, NO synthase activity is high in CNS ganglia containing motor networks for feeding and locomotion, where a cAMP-gated cation current (I Na,cAMP ) is also prominent in many neurons. We examined effects of NO on I Na,cAMP using voltage clamp methods developed to analyze cAMP signaling in the live neuron, focusing on the identified metacerebral giant neuron of the feeding network. NO donors enhanced the I Na,cAMP response to injected cAMP by an averaged 85%. In dose-response measures, NO increased the current stimulated by cAMP injection without altering either apparent cAMP binding affinity or cooperativity of current activation. NO did not detectably alter levels of native cAMP or synthesis or degradation rates, as observable in both current saturation and decay rate of I Na,cAMP responses to cAMP injection. NO actions were not exerted by cGMP signaling, as they were not mimicked by cGMP analog nor blocked by inhibitors of guanylate cyclase and protein kinase G. NO potentiation of I Na,cAMP was broadly distributed among many other neurons of the feeding motor network in the buccal ganglion. However, NO did not affect a second type of I Na,cAMP found in locomotor neurons of the pedal ganglia. These results suggest that NO acts through a novel mechanism to regulate the gain of cAMP-dependent neuromodulatory pathways that activate I Na,cAMP , and may thereby affect the set-points of feeding network excitability and reactivity to exogenous input.
Introduction
Actions of the cellular messenger NO are reflected in many facets of nervous system function, and new roles and mechanisms continue to emerge. Gastropod molluscs present markedly accessible systems for the integrated study of NO, where its actions are amenable to broad analysis at levels spanning single neurons to behavior (Elphick et al. 1995; Korneev et al. 2002; Gelperin 1994; Jacklet and Tiemann 2004; Katzoff et al. 2002) . In these animals NO and its synthetic enzyme NO synthase (NOS) are notably associated with sensory pathways, neural networks and anatomical structures that serve feeding behavior (c.f. Moroz 2000) .
Previous work in invertebrate systems has largely concerned the regulation of membrane conductances and synaptic release through the signaling pathway involving cGMP (Mothet et al. 1996; Koh and Jacklet 1999; Kemenes et al. 2002) , as have most studies in mammalian brain. However, NO is "promiscuous" with respect to its functional roles, signaling pathways and mechanisms of action in different biological systems, and new aspects of its physiology continue to be uncovered. In the predatory sea-slug Pleurobranchaea, NOS activity in the CNS is quite high and tentatively localized to numerous neurons in the feeding and locomotor motor networks Cruz et al 1997; Floyd et al. 1998b) . It is notable that many of those neurons also express a cAMP-gated sodium current (I Na,cAMP ) that contributes significantly to the excitable properties of the neurons (Green and Gillette 1983; Sudlow et al. 1995) . The co-occurrence of I Na,cAMP and NO led us to investigate NO effects on this ion current as a potential mechanism for regulating neuron excitability, particularly in the feeding motor network. We focused analyses on the identified serotonergic metacerebral giant interneurons (MCGs) of the feeding motor network, but surveyed NO sensitivity of I Na,cAMP across many neurons.
Prior work has characterized the kinetics of the I Na,cAMP response to injected cAMP in terms of activation, inactivation and saturation, thereby establishing the use of I Na,cAMP as a reporter for cAMP in the whole cell. The mathematical models derived and tested permit precise quantitation in molar terms for cAMP metabolism for synthesis, degradation and concentration Gillette 1991, 1993; Sudlow et al. 1993; Gillette 1995, 1997) . Thus, we took advantage of the exceptional opportunity in this system to investigate the possible interactions of the signaling pathways of NO and cAMP in the living neuron.
Two forms of I Na,cAMP have been identified in the CNS of Pleurobranchaea.
These two forms are differentially located in neurons of the feeding motor network of the buccal and cerebropleural ganglia (Type 1) and in locomotor neurons of the pedal ganglia (Type 2). The two currents are similar in ion selectivity and cAMP requirement but differ markedly in their voltage dependencies and sensitivities to Ca 2+ and H + (Green and Gillette 1983; Green and Gillette 1987; Gillette and Green 1988; Huang and Gillette 1993) . Here we report that NO potentiated the Type 1, but not the Type 2 form. The enhancement of the Type 1 I Na,cAMP was novel in its independence from mediation by cGMP and was not caused by altered cAMP synthesis, degradation nor sensitivity of current activation. NO-induced potentiation of I Na,cAMP presents a novel mechanism of neuromodulation.
Materials and Methods
Pleurobranchaea californica (80-500 g) were obtained from Sea Life Supply (Sand City, CA) and maintained at 12-13 o C in a closed, circulating sea water system. For CNS dissections, animals were anesthetized by chilling to 4 o C. The cerebropleural, pedal and buccal ganglia were removed and axotomized somata (dia. 80-400 µm) were prepared as previously for voltage clamping Gillette 1995, 1997) . Axotomized somata were placed in a recording chamber (1 ml) continuously superfused at 12-13° C with Pleurobranchaea saline (in mM: 420 NaCl, 10 KCl, 25 MgCl 2 , 25 MgSO 4 , 10 CaCl 2 , and 10 MOPS, adjusted to pH 7.5 with NaOH).
Solutions of the nitric oxide donors diethylamine/nitric oxide complex (DEA/NO) and spermine-nitric oxide complex (NO-spermine), and S-nitroso-N-acetylpenicillamine (SNAP; Research Biochemicals International, Natick, MA) were prepared in Pleurobranchaea saline immediately before use. Actual NO concentrations in physiological solutions are usually uncertain, given that NO donors are sensitive to variables such as temperature and considering that NO gas oxidation rate is dependent on the partial pressure of O 2 . We checked NO concentrations in our experimental chamber with NO-sensitive electrodes (ISO-NOP detector with 100 nm tip electrode sensors;
(WPI) World Precision Instruments, Inc., Sarasota, FL). Electrodes were calibrated in N 2 -bubbled saline solutions of DEA/NO yielding known concentrations of NO in anoxic conditions. In aerated saline (1 ml) at 12° C in the voltage clamp preparation chamber, the relation between NO and DEA/NO concentrations was linear between zero and 2 mM. 1 mM DEA/NO in the recording chamber measured in this manner initially yielded 430 nM NO with first-order exponential decay (t ½= 418 seconds). Unless otherwise stated, experimental treatments were performed with this concentration of DEA/NO. Experimental exposures to DEA/NO rarely lasted much longer than a single half-life for DEA/NO (although see Fig. 4 ). However it seems unlikely that changing NO levels affected the qualitative outcomes of these experiments given both the near saturation effects of DEA/NO at the concentration used (Results), the relatively long recovery period following washout (Results), and the smoothness of the relations of Figures 2, 3, 6 and 8 which were built from multiple data points. When used, NO-sensitive electrodes used to directly monitor saline NO concentrations were calibrated both before and after experiments. Depleted NO donor controls were produced by exposing donor solutions to air at room temperature for 24 hours or more before use.
The membrane permeable analog of cyclic-3', 5'-guanosine monophosphate, 8-Br-cGMP (20 µM; RBI), was mixed in Pleurobranchaea saline. Soluble guanylate cyclase inhibitor ODQ (1H-[1,2,4]oxadiazolo[4, 3-a]quinoxaline-1-one) and protein kinase G inhibitor KT5823 (Sigma Chemicals, Saint Louis, MO) were prepared as millimolar stock solutions in DMSO; final dilutions in saline to 20 µM ODQ and 1 µM KT5823 concentrations resulted in DMSO present in amounts less than 0.1% in experimental solutions. 8-Br-cGMP, ODQ and KT5823 were chosen based on their reported efficacies and previous use in molluscan neurons (Koh and Jacklet 1999; Mothet et al. 1996) . I Na,cAMP responses to iontophoretic injection of cAMP were measured under two electrode voltage clamp with a third headstage maintaining a bath clamp as a virtual ground via an agar bridge. Sharp electrodes were pulled from borosilicate glass (WPI). A singlebarreled capillary filled with 3M KCl served as a voltage-sensing electrode. A second, double-barreled, electrode acted as the current passing electrode (filled with 3 M KCl) in one half and a cAMP iontophoresis capillary in the other (filled with 200 mM cAMP and 20 mM Tris, adjusted to pH 7.5 with KOH). Iontophoretic injection of cAMP (5 s duration; 5-6 2000 nA unless otherwise stated) was accomplished with negative current from a constant current source (Model 260, WPI) that allowed precise, repeatable quantities of cAMP to be injected intracellularly. Under our experimental conditions, cAMP injection occurs with a constant transport number of 0.1 over the wide range of injection currents used here (Sudlow and Gillette 1997) . Intracellular recording and voltage clamping were performed with an Axoclamp 2B amplifier (Axon Instruments, Union City, CA), and data were recorded digitally with Biopac hardware and the accompanying Acknowledge software package (Biopac Systems, Inc., Goleta, CA). All recordings were performed at a holding potential of -50 mV unless otherwise indicated. The kinetics of I Na,cAMP are largely determined by intracellular cAMP diffusion and phosphodiesterase activity (Huang and Gillette 1991) Comparisons of phosphodiesterase degradation rates were performed as per Huang and Gillette (1991) . Briefly, I Na,cAMP decay slopes, sensitive reflections of intracellular cAMP levels, were fit with Equation 2 by the method of least squares with the first order exponential decay:
(2)
where I equals I Na,cAMP amplitude, I 0 is the initial current amplitude at the start of the decay slope measure, t is time in seconds and k h is the inverse of the time decay constant expressed in units of seconds -1 . Here, k h is used as an index of intracellular phosphodiesterase activity in Pleurobranchaea neurons (see Sudlow and Gillette 1997) .
Statistical analyses were performed with Instat software, version 2.03 (Graphpad Software, Inc., San Diego, CA). Paired t-tests were used for statistical comparisons unless otherwise stated. Error bars in histograms indicate standard error of the mean (SEM).
Results

NO potentiation of Type 1 I Na,cAMP in Metacerebral Giant Neurons
NO donors enhanced the Type 1 I Na,cAMP response to injected cAMP in the MCGs ( Fig. 1 ) and numerous other identified members of the feeding motor network. To elucidate NO effects in MCG neurons, we measured cAMP dose-response before and during NO treatment in six experiments. Figure 2A shows the dose-response curve fitted with Equation 1 for one experiment. NO enhancement of I Na,cAMP was accompanied by an increase in the projected maximum current available for activation by cAMP.
However, there were no apparent changes in the dissociation constant (K c ) nor the Hill coefficient (n). In such dose response curves, when n is close to 1.0, double reciprocal plots of the hyperbolic curve yield linear relations where the Y-intercepts are equal to 1/I Max and the X-intercepts are equal to -1/K c . The double reciprocal plots were linear both before and after NO superfusion ( Fig. 2B) , with n values close to 1.0, implying that there was no induced change in cooperativity of cAMP activation of I Na,cAMP .
Additionally, extrapolated K c values from before and during DEA/NO donor were relatively unchanged, while I Max values were increased following NO treatments. Figure   2C summarizes these results for all six cAMP dose-response experiments following NO enhancement of I Na,cAMP .
In three separate experiments we tested the effects of NO on steady-state I Na,cAMP , achieved by tonic cAMP injection, and found that it was potentiated similarly to pulsed cAMP responses ( Figure 3 ). Ionotophoretic injection values used were well below current saturation to avoid confounding, use-dependent effects on phosphodiesterase activity and subsequent I Na,cAMP amplitudes commonly observed with continuous injections of large amounts of cAMP (Sudlow and Gillette 1997 Depleted NO donors had no detectable effects on I Na,cAMP , while fresh DEA/NO applied thereafter markedly increased I Na,cAMP amplitude in one MCG (Fig. 4A,B ) and in three buccal cells. The donors NO-spermine (0.2 mM, N=4) and SNAP (0.2 mM, N=3)
were also tested on buccal neurons with positive results. In a fifth experiment, neither depleted 1mM SNAP nor depleted 1 mM spermine-NO negative controls enhanced I Na,cAMP in a buccal cell, while fresh spermine-NO increased the current 52%. The specific effectiveness of the fresh NO donors indicated that the effects did not result from decay products of the donors and were most likely specific effects of NO. The latency of NO potentiation was too short for exact measure by our protocols, and may have been initiated quite shortly after actual contact with NO.
NO potentiation of I Na,cAMP was slowly reversible upon donor washout. Figure 4B shows a timecourse for addition and washout of NO donor from one experiment. The I Na,cAMP response was rapidly potentiated upon addition of DEA/NO saline, then declined over 10 minutes to a lower value that remained constant in the presence of DEA/NO.
Upon washout, the response declined slowly over 10s of minutes approaching pre-donor baseline. The experiment of Figure 4 was specifically aimed at assessing timecourse, and was unusual in its long duration (nearly 2 hours); such frequent and numerous tests of injected cAMP typically lead to an artifact evident in the later stages of the experiment: use-dependent prolongation of the decay of the I Na,cAMP response and steadily increasing amplitude (Sudlow and Gillette, 1997 ) -this was not a specific effect of NO, but an event often occurring over long recording periods probably due to steady loss of phosphodiesterase activity (see further).
NO and the voltage dependence of I Na,cAMP
The Type 1 I Na,cAMP normally shows increasing amplitude with depolarization from rest up to around -30 mV. Slow command voltage ramps revealed simple potentiation of I Na,cAMP following treatment with 1 mM DEA/NO throughout the range of -80 to -30 mV, with no marked change in the current/voltage relation ( Fig. 5A ). Similar results were obtained by measuring I Na,cAMP amplitudes in response to pulsed cAMP injections at -60, -40 and -30 mV (not shown). Subtraction of leak currents before and after DEA/NO treatment showed no measurable current induction in the absence of cAMP injection within this voltage range (Fig. 5B ).
NO and cAMP saturation effects on I Na,cAMP NO alters cAMP synthesis and degradation in a variety of systems (McVey et al. 1999; Kurtz et al. 1998) . We tested for possible actions on cAMP pathways that might mediate NO effects on I Na,cAMP or other aspects of cell function. The effect of current saturation on I Na,cAMP amplitude is readily observed when a pulsed I Na,cAMP response is superimposed on a steady-state I Na,cAMP background induced by tonic cAMP injection. Figure 6A illustrates the paradigm for measurement of I Na,cAMP current saturation. The occlusion ratio, (I-I 0 )/I, is a direct measure of current saturation, where I 0 is the test pulse response measured during imposed background steady-state I Na,cAMP and I is the control response Sudlow and Gillette 1995) . When (I-I 0 )/I was plotted against steady-state I Na,cAMP for three MCG and two buccal motor neurons, the relationship was linear with increasing background I Na,cAMP and was not altered by NO donor (Fig. 6B; N=5 ).
NO and intracellular cAMP
In the intact cell, I Na,cAMP responses are shaped by the activities of endogenous phosphodiesterase and adenylate cyclase. These enzyme activities determine the saturation state of I Na,cAMP by setting resting levels of cAMP and determine the rate of I Na,cAMP decay through cAMP degradation. Measures of both phosphodiesterase kinetics and cAMP levels in the intact cell are possible using I Na,cAMP as a reporter of intracellular cAMP dynamics via measures of latency-to-peak I Na,cAMP amplitudes, as well as through first-order exponential fits of I Na,cAMP decay slopes (Huang and Gillette 1991; Sudlow and Gillette 1997) . To test the effect of NO on cAMP metabolism, I Na,cAMP decay rates and latencies to peak following pulsed cAMP iontophoretic injection were compared in 11
MCGs. Figure 7A overlays two I Na,cAMP responses to identical cAMP injections in the same MCG neuron before and following DEA/NO-induced current potentiation. It can be readily observed that the latency-to-peak amplitude is unchanged following NO treatment, while amplitude is enhanced. To further test for possible effects on cAMP metabolism, I Na,cAMP exponential decay slopes were fitted with Equation 2 to obtain decay rate constants (k h ) indicative of phosphodiesterase degradation rates of cAMP ( Fig. 7B ).
NO treatment failed to alter either latency to peak or k h . These data are summarized in figures 7C and 7D. Inhibition of PDE has previously been reported to elevate I Na,cAMP amplitudes but is accompanied with a characteristic increase of the latency to peak amplitude as well as a decreased decay slope ( Fig 7E, reprinted from Huang and Gillette 1991), two readily observable effects on I Na,cAMP that NO potentiation does not exhibit.
NO and cGMP effects on I Na,cAMP
Intracellular signaling pathways for NO are often found to be mediated by cGMP through direct activation of soluble guanylate cyclase (Garthwaite and Boulton 1995) .
Accordingly, in separate experiments on MCGs we tested the membrane permeant cGMP analog 8-bromo-cGMP (20 µM), an inhibitor of soluble guanylate cyclase, ODQ (20 µM), and the specific protein kinase G inhibitor KT5823 (1 µM) on I Na,cAMP . NO enhancement of I Na,cAMP was not mimicked by 8-Br-cGMP, whereas NO donor was active on the same cells ( Fig. 8A) . Additionally, perfusion of 20 µM 8-Br-cGMP did not detectably alter ion current in MCG preparations, nor did it cause detectable occlusion of the I Na,cAMP response. The guanylate cyclase inhibitor ODQ (20 µM) and the inhibitor of PKG, KT5823 (1 µM), had no effects on the I Na,cAMP response to injected cAMP and did not suppress NO potentiation of I Na,cAMP amplitudes (Fig. 8B,C) . Moreover, no changes in basal currents were observed following perfusion of either ODQ or KT5823. Each experiment was performed four separate times (a total of 12 cells, summarized in figure 7D ). Additionally, in other experiments even higher concentrations of 8-Br-cGMP were tested on the MCG (100 µM;
N=1), and on buccal motorneurons (1 mM; N=4) with no potentiating effects on I Na,cAMP .
These results are consistent with previous, unpublished results of iontophoretic injections of cGMP The distribution of NO effects on I Na,cAMP
In exploratory experiments NO donors markedly enhanced the Type 1 I Na,cAMP found in feeding neurons of diverse identities, but not the Type 2 I Na,cAMP of the G neurons (serotonergic putative locomotion effectors; Sudlow et al. 1998 ) of the pedal ganglia ( Fig. 9) . Results for 27 different neurons, axotomized from the buccal, cerebropleural, visceral and pedal ganglia, are summarized in Table 1 . Of these neurons, those specifically identified were the ventral white cell feeding command neuron of the buccal ganglion , the VG1 neuron of the visceral ganglion , and the MCGs of the cerebropleural ganglia (Gillette and Davis 1977) . Increasing DEA/NO concentration from 0.1 to 0.2 mM after 10-15 minutes at the lower concentration in 5 neurons caused further increase of I Na,cAMP amplitude by 5-55%; however, the increase was not significant (p>0.05; 2-tailed t-test), suggesting near-saturation of the NO dose-I Na,cAMP response relation at the lower concentrations. In contrast, NO donor treatment of the Type 2 I Na,cAMP tested in ten pedal G locomotory neurons from 4 animals failed to cause detectable increases in the Type 2 current.
Discussion
The present findings support a role for NO in modulating the activity and reactivity of neurons of the feeding motor network through selective amplification of Type 1 I Na,cAMP . In addition, the experimental observations appear to exclude common intracellular signaling pathways that mediate effects of NO in other systems and suggest alternate avenues for future investigations.
Distinctiveness of NO Signaling in this System
NO modulation of I Na,cAMP is not consistent with several well-understood pathways of action in other systems. It is distinctly different from those effects described for other cyclic nucleotide-gated cation currents, those of vertebrate olfactory receptor and retinal photoreceptor cells. In the retina, NO enhances cGMP-gated current through stimulation of cGMP synthesis (Savchenko et al. 1997 ). However, NO potentiation of I Na,cAMP appears to be independent of the cGMP signaling pathway. The effects of NO were not blocked or attenuated by inhibitors of guanylate cyclase and PKG. The membrane permeant cGMP analog 8-Br-cGMP failed to either mimic or occlude NO effects. Thus, NO is unlikely to act here through stimulation of the synthesis of cGMP or through cGMP-dependent phosphorylation. These results recall previous observations (Gillette et al. 1982 ) that cGMP analogs are relatively ineffective at stimulating activity in the intact feeding motor network in Pleurobranchaea where I Na,cAMP is widely present.
Olfactory cAMP-gated channels can be activated by NO through direct nitrosylation of C-terminal cysteine residues in the absence of the gating nucleotide (Broillet 2000) . Pleurobranchaea I Na,cAMP differs, in that the action of NO on I Na,cAMP is dependent on the presence of cAMP. Here, the augmenting effect of NO is through potentiation, and not co-activation. The present experimental system stands out in providing a sound basis for investigation of possible roles for cAMP in mediating effects of NO in living neurons, using relatively simple voltage clamp methodology. Our previous comprehensive studies of the kinetics of I Na,cAMP in molluscan neurons enabled quantitative breakdown of cAMP paths of action with respect to diffusion and degradation (Huang and Gillette 1991) , cAMP channel binding affinity , direct gating by cAMP (Sudlow et al. 1993) , and synthetic rate and intracellular concentrations (Sudlow and Gillette 1997) . When these methods were applied here, effects of NO on known cAMP pathways could be tested and, in some cases, excluded. This contrasts with a number of other systems in which NO can affect the levels, synthesis and degradation of cAMP (e.g., Kurtz et al. 1998; McVey et al. 1999) .
NO-induced changes in the binding affinity of cAMP with the I Na,cAMP channel were absent. Hill fits of the dose-response curves before and after NO treatment showed marked enhancement of I Na,cAMP amplitudes at all cAMP injection values below saturation. There was no evident change in the apparent affinity of cAMP for the channel, as observed as an unchanging K c value, or in the number of cAMP molecules required to bind the channel and activate the current. There was no change in any potential cooperativity between channel subunits with cAMP binding, as reflected in the constancy of the Hill coefficient (n) of 1.
NO did not induce evident changes in either native cAMP concentrations or the rate of cAMP hydrolysis, since the decay rates and latencies to peak amplitude of I Na,cAMP responses to test pulses of cAMP, sensitive indicators of both in vivo cAMP concentration and phosphodiesterase activity (Huang and Gillette 1991; Sudlow and Gillette 1995) , were unaltered by NO donors. This interpretation is further supported by the unchanging cAMP saturation plots following NO treatment. If NO had elevated cAMP through adenylyl cyclase activation and/or phosphodiesterase inhibition, plots of the occlusion ratio would have been shifted markedly to the left, reflecting increased saturation of I Na,cAMP . This methodology was previously employed to establish that serotonin stimulated adenylyl cyclase and cAMP levels in Pleurobranchaea G neurons (Sudlow and Gillette 1995) . Moreover, possible NO-induced increase in maximal enhancement of I Na,cAMP , through an increase in the number of channels available, was not supported by our finding that cAMP saturation fits were unchanged following NO treatment.
NO did not act by altering the voltage dependence of the Type 1 I Na,cAMP , which is mediated by a likely depolarization-sensitive Ca 2+ block of the channel (Green and Gillette 1987) . Current-voltage plots of steady-state I Na,cAMP showed an NO-induced inward shift, but no change in slope between -100 to -30 mV. No other effects on leak currents were detected.
The mechanism for selective NO enhancement of Type 1 I Na,cAMP , but not Type 2, has yet to be defined. Its independence from both the cGMP and cAMP pathways suggests regulatory actions that are not as well known. For example, NO might act through direct nitrosylation of cysteine residues in proteins (Xu et al. 1998) . Regulation in these neurons might also involve NO-induced change in intracellular pH (McCrohan et al. 2005) ; type 1 I Na,cAMP amplitudes have previously been reported to be sensitive to alterations of intracellular pH (Green and Gillette 1988) . When found, the target of NO in this system may reveal a novel regulatory mechanism of cell excitability.
Physiological Relevance
Expression of NO and NOS in feeding-related neural circuitry are traits shared across species of gastropod molluscs. Chemosensory activation of the feeding motor network in Lymnaea appears to depend on NO (Elphick et al. 1995) , and NO itself stimulates feeding motor output in both isolated CNS and semi-intact preparations of Lymnaea (Moroz et al. 1993) , as also in Pleurobranchaea (unpublished results). However, there is marked variability in the apparent expression, localization and Ca 2+ dependence of NOS activity across species, which may reflect the long evolutionary history and broad diversification in the feeding ecology of the members of the class (see reviews by Moroz and Gillette 1995; . The present observations add another novel aspect in NO potentiation of Type 1 I Na,cAMP , which represents a new neuromodulatory pathway.
In neurons of the pond snail Lymnaea and the sea-hare Aplysia, NO stimulates excitability through cGMP-dependent reduction of a K + conductance (Park et al. 1998; Jacklet and Tieman 2004 Thus, NO stimulation of I Na,cAMP is potentially more widely spread among gastropods, and perhaps other taxa.
What is the likely role of NO in this system? At levels of cell and circuit, NO is liable to amplify neuromodulator-induced cAMP. Thus, our emerging picture of the functional role of NO in the feeding motor network of Pleurobranchaea is one where it acts as a gain-enhancing mechanism, boosting the cellular responses to neuromodulatorinduced fluctuations of cAMP. Such gain-control would in turn affect the activity state of the feeding network, in part through broad modulation of I Na,cAMP in its neural elements. Huang and Gillette (1991) emphasize that increasing the concentration of the PDE inhibitor IBMX increases latencies to peak amplitude and decreases decay rate of I Na,cAMP responses. Peak amplitudes initially increase, and then decline due to I Na,cAMP saturation by background cAMP. Numbers indicate I Na,cAMP response recordings in 0 (1), 10 (2), 20 (3), 50 (4), 100 (5), and 600 µM IBMX (6). Type 2 current in a locomotor G neuron of the pedal ganglia was unaffected (N=10). See Table 1 . 
Figure Legends
Figure 7.
Evidence that phosphodiesterase activity remains unaltered following NO enhancement of I Na,cAMP . A. Overlays of I Na,cAMP responses in an MCG neuron to discrete cAMP injections (-100 nA, 5 second duration) before ( ) and after ( ) 1 mM DEA/NO perfusion. Although I Na,cAMP amplitude increases following NO treatment, the latency to peak (7.5 seconds) remains unchanged. B. Plots of the absolute values of the I Na,cAMP in (A) past 9 seconds follow first-order exponential decay relations. Fits of decay slopes before and after NO treatment with Equation 2 give exponential constants indicative of phosphodiesterase activity (k h ). Here, k h values before and after NO treatment remain relatively unchanged at 0.429 s -1 and 0.463 s -1 respectively (exponential decay data fit by the method of least squares: control r 2 = 0.995, Chi 2 = 0.00008; DEA/NO r 2 = 0.994, Chi 2 = 0.00036). C. A summary histogram for 11 cells comparing latency to peak amplitude shows no significant difference in the time to peak after NO treatment (p= 0.46; paired ttest; error bars indicate SEM, N=11). D. Comparison of k h values before and after NO enhancement of I Na,cAMP suggest that no change in phosphodiesterase activity occurs (p= 0.979 paired t-test; error bars indicate SEM; N=11; r 2 for all fits are 0.97 and Chi 2 < 0.05). E. Records reproduced from Huang and Gillette (1991) emphasize that increasing concentrations of the PDE inhibitor IBMX increases latencies to peak amplitude and decreases decay rate of I Na,cAMP responses. Peak amplitudes initially increase, and then decline due to I Na,cAMP saturation by background cAMP. Numbers indicate I Na,cAMP response recordings in 0 (1), 10 (2), 20 (3), 50 (4), 100 (5), and 600 µM IBMX (6). Figure 8 . NO enhancement of I Na,cAMP is independent of cGMP. A. The membranepermeant analog, 8-bromo-cGMP (20 µM), did not alter the cAMP dose response curves for I Na,cAMP peak amplitudes. Dose response curves were fitted with Equation 1 in normal saline (r 2 =0.993), 8-Br-cGMP (r 2 =0.995) and DEA/NO + 8-Br-cGMP (r 2 =0.998) containing salines. Subsequent bath addition of DEA/NO + 8-Br-cGMP readily increased I Na,cAMP amplitudes in the same cell. B. Enhancement of I Na,cAMP by DEA/NO persisted in the presence of 20 µM ODQ, an inhibitor of soluble guanylate cyclase. Dose response data were fitted with Equation 1 in normal saline (r 2 = 0.998), ODQ (r 2 = 0.993), and after DEA/NO+ODQ (r 2 = 0.999) perfusion. C. Perfusion of 1 µM KT5823, a selective PKG inhibitor, did not alter I Na, cAMP dose response curves (r 2 =0.998, control; r 2 =0.994, KT5823 treatment) or suppress I Na,cAMP enhancement by DEA/NO superfusion (r 2 =0.995). D. A summary histogram compares percent increases over control injections at -300 nA of cAMP for 8-Br-cGMP, ODQ and KT5823 with percent increases in amplitude following NO treatments. Each experiment were done 4 times (12 cells total; error bars indicate SEM; * p<0.001, one-population t-test). Figure 9 . NO enhances the Type 1 I Na,cAMP in feeding motor neurons but not the Type 2 I Na,cAMP of locomotor neurons. Top record: NO donor potentiation of the Type 1 I Na,cAMP response to injected cAMP in a buccal motor neuron (MN; N=18). Lower record: The Type 2 current in a locomotor G neuron of the pedal ganglia was unaffected (N=10). See Table 1 .
